These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34651470)

  • 1. Valproate Efficacy for Agitation Management in a Patient With Paroxysmal Sympathetic Hyperactivity Due to Traumatic Brain Injury.
    Chen A; Sharoha N
    Prim Care Companion CNS Disord; 2021 Oct; 23(5):. PubMed ID: 34651470
    [No Abstract]   [Full Text] [Related]  

  • 2. Admission Features Associated With Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury: A Case-Control Study.
    Podell JE; Miller SS; Jaffa MN; Pajoumand M; Armahizer M; Chen H; Tripathi H; Schwartzbauer GT; Chang WW; Parikh GY; Hu P; Badjatia N
    Crit Care Med; 2021 Oct; 49(10):e989-e1000. PubMed ID: 34259439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine Treatment for Agitation Following Traumatic Brain Injury.
    Whiting WL; Sullivan GA; Stewart JT
    Psychosomatics; 2016; 57(3):330-3. PubMed ID: 27005724
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining community living with post brain injury agitation: a role for sodium valproate.
    Connolly S; Caldwell SB; Wilson FC
    Brain Inj; 2013 Jun; 27(6):754-7. PubMed ID: 23611543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of olanzapine to treat agitation in traumatic brain injury: study protocol for a randomised controlled trial.
    Phyland RK; McKay A; Olver J; Walterfang M; Hopwood M; Hicks AJ; Mortimer D; Ponsford JL
    Trials; 2020 Jul; 21(1):662. PubMed ID: 32690072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative sedation: An option for the management of agitation in moderate traumatic brain injury.
    Godoy DA; Tolosa K; Lubillo-Montenegro S; Murillo-Cabezas F
    Med Intensiva; 2017 Apr; 41(3):193-196. PubMed ID: 27085767
    [No Abstract]   [Full Text] [Related]  

  • 9. Paroxysmal Sympathetic Hyperactivity Syndrome Following Traumatic Brain Injury.
    Compton E
    Nurs Clin North Am; 2018 Sep; 53(3):459-467. PubMed ID: 30100010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traumatic Brain Injury in COVID-19 Patients with the Manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm.
    Sami Z; Javed A
    CNS Neurol Disord Drug Targets; 2023; 22(6):786-788. PubMed ID: 35450535
    [No Abstract]   [Full Text] [Related]  

  • 11. The Use of Atypical Antipsychotics for Managing Agitation After Traumatic Brain Injury.
    McKay A; Trevena-Peters J; Ponsford J
    J Head Trauma Rehabil; 2021 May-Jun 01; 36(3):149-155. PubMed ID: 32898031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for agitated behaviours in patients with traumatic brain injury: a systematic review.
    Williamson D; Frenette AJ; Burry LD; Perreault M; Charbonney E; Lamontagne F; Potvin MJ; Giguère JF; Mehta S; Bernard F
    BMJ Open; 2019 Jul; 9(7):e029604. PubMed ID: 31289093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Pathological Features and Scheduled Pharmacological Therapies.
    Pozzi M; Conti V; Locatelli F; Galbiati S; Radice S; Clementi E; Strazzer S
    J Head Trauma Rehabil; 2017; 32(2):117-124. PubMed ID: 27603764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood Stabilizers for Traumatic Brain Injury-Related Agitation.
    Kalra ID; Watanabe TK
    J Head Trauma Rehabil; 2017; 32(6):E61-E64. PubMed ID: 29095772
    [No Abstract]   [Full Text] [Related]  

  • 15. Agitated symptom response to divalproex following acute brain injury.
    Chatham Showalter PE; Kimmel DN
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):395-7. PubMed ID: 10956575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic Acid for the Management of Agitation and Delirium in the Intensive Care Setting: A Retrospective Analysis.
    Crowley KE; Urben L; Hacobian G; Geiger KL
    Clin Ther; 2020 Apr; 42(4):e65-e73. PubMed ID: 32273047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate in the treatment of behavioral agitation in elderly patients with dementia.
    Lott AD; McElroy SL; Keys MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):314-9. PubMed ID: 7580190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis.
    Williamson DR; Frenette AJ; Burry L; Perreault MM; Charbonney E; Lamontagne F; Potvin MJ; Giguère JF; Mehta S; Bernard F
    Syst Rev; 2016 Nov; 5(1):193. PubMed ID: 27855720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury in Children: Prevalence, Risk Factors, and Outcome.
    Alofisan TO; Algarni YA; Alharfi IM; Miller MR; Charyk Stewart T; Fraser DD; Tijssen JA
    Pediatr Crit Care Med; 2019 Mar; 20(3):252-258. PubMed ID: 30489486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Rothenburg LS; Eryavec G
    Dement Geriatr Cogn Disord; 2007; 23(2):116-9. PubMed ID: 17148938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.